Jonathan Pol

38PUBLICATIONS

90CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsToxicology (incl. clinical toxicology)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (38)

Sort by Publication Date:

|Jun 03, 2026

Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.

|Apr 02, 2026

Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation.

Flavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde

|Nov 28, 2025

ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases.

Sijing Li, Flavia Lambertucci, Léa Montégut

|Aug 16, 2025

Neutralization of the autophagy-repressive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) for the treatment of hepatocellular carcinoma.

Sijing Li, Flavia Lambertucci, Isabelle Martins

|Jul 10, 2025

Disruption of cholesterol homeostasis by antidepressants induces immunogenic cell death.

Karla Alvarez-Valadez, Jonathan G Pol, Guido Kroemer

|Jun 18, 2025

Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors.

Lucille Ferret, Jonathan G Pol, Allan Sauvat

Pageof 7

Frequent Collaborators

25 joint publications

Guido Kroemer

Maria Chiara Maiuri

Oliver Kepp

Juliette Paillet

Allan Sauvat

Francesco Salvatore

Gautier Stoll

Fatima Domenica Elisa De Palma

3 joint publications

Julie Le Naour

3 joint publications

Isabelle Martins

Frequent Collaborators

25 joint publications

Guido Kroemer

6 joint publications

Maria Chiara Maiuri

6 joint publications

Oliver Kepp

5 joint publications

Juliette Paillet